|
Rigel commences two Phase II allergic asthma and DLE studies
Equities.com Approximately 270 adults with allergic asthma will be randomized into the three arms of this Phase II clinical study of R343, called SITAR, or SYK Inhibition for Treatment of Asthma with R343, for eight weeks of treatment with either of two different … |
View full post on asthma – Google News